Health Law Forecast 2026
January 1, 2026
By: James W. Attridge, Lisl J. Dunlop, Leslie C. Overton
AHLA Health Law Connections Magazine - Volume 7, Issue 1
Axinn partners Jimmy Attridge, Lisl Dunlop, and Leslie Overton co-authored the American Health Law Association article, "Health Law Forecast 2026," published in the Health Law Connections magazine.
Click here to access the publication. A subscription is required.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
Seven Axinn Attorneys Named to 2025 Capital Pro Bono Honor Roll
Pro Bono
Antitrust
Axinn Advises Thermo Fisher Scientific on $1.075 Billion Sale of its Microbiology Business to Astorg
Deals & Cases
Antitrust
Axinn Appoints Rachael Philbin as Chief Innovation Officer
News
Teva v. Lilly -- Clarifies Written Description of Method Claims Involving A Genus
Axinn Viewpoints
Intellectual Property
What’s Up? Competition Enforcement Updates From Italy and Portugal
Podcast
Antitrust
ACI 22nd Annual Paragraph IV Conference
Speaking Engagement
Intellectual Property
Informa 35th Annual Advanced EU London Conference
Speaking Engagement
Antitrust
Antitrust Fault Lines: Will Licensing Negotiation Groups Reshape SEP Licensing?
Byline Articles
Antitrust
AHLA Health Care Transactions Program 2026
Sponsorship
Antitrust
Kenina Lee Selected as a Member of Law360’s 2026 Competition Editorial Advisory Board
Awards & Recognitions
Antitrust